WoS SCIE & CAS Academic Rankings
Global Journal Rankings & Directory
Explore academic hierarchies, Clarivate Impact Factors, Web of Science Q1–Q4 quartiles, and CAS divisions.
Showing 1–25 of 102 international scientific journals (Toxicology and Pharmaceutics)
| Rank | Journal Name & ISSN | Impact Factor | H-Index | WoS Quartile | Scopus SJR | CAS Division | Self-Citation | Docs/yr | Publisher |
|---|---|---|---|---|---|---|---|---|---|
| #1 | Acta Pharmaceutica Sinica B ISSN: 2211-3835 / 2211-3843Top Tier | 14.6 | 146 | Q1 | 3.439Q1 | CAS Tier 1 | 5.4% | 263 | Elsevier BV |
| #2 | Asian Journal of Pharmaceutical Sciences ISSN: 1818-0876 / 2221-285XTop TierDiamond OA | 12.6 | 87 | Q1 | 2.196Q1 Diamond OA | CAS Tier 1 | 4.7% | 60 | Shenyang Pharmaceutical University |
| #3 | International Journal of Pharmaceutics: X ISSN: 2590-1567 | 7.9 | 37 | Q1 | 1.101Q1 | CAS Tier 2 | N/A | 187 | Elsevier |
| #4 | Current Molecular Pharmacology ISSN: 1874-4672 / 1874-4702 | 7.2 | 54 | Q1 | 1.024Q1 | CAS Tier 2 | 0% | 97 | Bentham |
| #5 | Pharmaceutics ISSN: 1999-4923 | 6.9 | 157 | Q1 | 1.197Q1 | CAS Tier 2 | 12.2% | 2,132 | MDPI (Basel, Switzerland) |
| #6 | Bioengineering & Translational Medicine ISSN: 2380-6761Top Tier | 6.2 | 48 | Q1 | 1.446Q1 | CAS Tier 2 | 3.3% | 69 | Wiley-Blackwell |
| #7 | Cancer Nanotechnology ISSN: 1868-6958 / 1868-6966 | 5.8 | 46 | Q2 | 0.849Q1 | CAS Tier 3 | 4.4% | 33 | Springer Vienna |
| #8 | Pharmaceuticals ISSN: 1424-8247 | 5.7 | 120 | Q1 | 1.14Q1 | CAS Tier 2 | 4.7% | 1,309 | Multidisciplinary Digital Publishing Institute (MDPI) |
| #9 | Antibiotics-Basel ISSN: 2079-6382 | 5.5 | 124 | Q1 | 1.276Q1 | CAS Tier 3 | 14% | 1,519 | Multidisciplinary Digital Publishing Institute (MDPI) |
| #10 | Journal of Pharmaceutical Investigation ISSN: 2093-5552 / 2093-6214 | 4.7 | 50 | Q1 | 0.946Q1 | CAS Tier 3 | 7.5% | 30 | Springer Nature |
| #11 | SCIENTIA PHARMACEUTICA ISSN: 0036-8709 / 2218-0532 | 3.6 | 61 | Q2 | 0.519Q2 | CAS Tier 4 | 4.3% | 51 | Multidisciplinary Digital Publishing Institute (MDPI) |
| #12 | Diabetes Metabolic Syndrome and Obesity-Targets and Therapy ISSN: 1178-7007 | 3.5 | 80 | Q2 | 0.89Q2 | CAS Tier 3 | 3.6% | 439 | Dove Medical Press Ltd. |
| #13 | Vaccines ISSN: 2076-393X | 3.5 | 111 | Q2 | 0.955Q1 | CAS Tier 3 | 17.3% | 1,440 | MDPI (Basel, Switzerland) |
| #14 | Journal of Applied Research on Medicinal and Aromatic Plants ISSN: 2214-7861 | 3.4 | 47 | Q2 | 0.637Q2 | CAS Tier 2 | 7.9% | 81 | Elsevier GmbH |
| #15 | Toxicon: X ISSN: 2590-1710 | 3.2 | 25 | Q2 | 0.607Q3 | CAS Tier 3 | N/A | 15 | Elsevier |
| #16 | Pharmacology Research & Perspectives ISSN: 2052-1707 | 2.6 | 53 | Q3 | 0.742Q1 | CAS Tier 3 | 0% | 188 | Wiley-Blackwell |
| #17 | Bioimpacts ISSN: 2228-5652 / 2228-5660Diamond OA | 2.5 | 50 | Q3 | 0.568Q2 Diamond OA | CAS Tier 4 | 4.5% | 59 | Tabriz University of Medical Sciences |
| #18 | Drugs in Research & Development ISSN: 1174-5886 / 1179-6901 | 2.5 | 58 | Q3 | 0.918Q2 | CAS Tier 3 | 4.5% | 36 | Springer International Publishing |
| #19 | Current Opinion in Toxicology ISSN: 2468-2020 | 2.4 | 52 | Q3 | 1.03Q1 | CAS Tier 4 | 0% | — | Elsevier |
| #20 | Current Pharmacology Reports ISSN: 2198-641X | 1.8 | 43 | Q3 | 0.499Q3 | CAS Tier 4 | N/A | — | Springer Nature |
| #21 | Revista Brasileira De Farmacognosia-Brazilian Journal of Pharmacognosy ISSN: 0102-695X / 1981-528XDiamond OA | 1.7 | 68 | Q4 | 0.377Q2 Diamond OA | CAS Tier 4 | 7.1% | 100 | Springer International Publishing |
| #22 | Contemporary Clinical Trials Communications ISSN: 2451-8654 | 1.5 | 34 | Q4 | 0.625Q2 | CAS Tier 4 | 0% | 169 | Elsevier |
| #23 | the Indian Journal of Pharmacy ISSN: 0019-5472 / 1998-3751 | 1.2 | 75 | Q4 | 0.35Q3 | CAS Tier 4 | 0% | 48 | Wolters Kluwer Health |
| #24 | Accounting ISSN: 2369-7393 / 2369-7407 | N/A | — | — | — | — | N/A | 5 | Growing Science |
| #25 | Acta Marisiensis - Seria Medica ISSN: 2247-6113 / 2668-7763 | N/A | 6 | — | 0.171Q3 | — | N/A | — | Sciendo |